Search results

Source:

Medicines and Healthcare products Regulatory Agency - MHRA (Add filter)

Source:

GOV UK (Remove filter)

Published by Medicines and Healthcare products Regulatory Agency, 01 September 2015

Guidance for safe use in medical, surgical, dental and aesthetic practices

Type:

Prescribing and Technical Information (Remove filter)

Source:

Medicines and Healthcare products Regulatory Agency - MHRA (Add filter)

Source:

GOV UK (Remove filter)

Published by Medicines and Healthcare products Regulatory Agency, 01 December 2013

Guidance for healthcare professionals on the use and management of blood pressure management devices.

Type:

Prescribing and Technical Information (Remove filter)

Source:

Medicines and Healthcare products Regulatory Agency - MHRA (Add filter)

Source:

GOV UK (Remove filter)

Published by Medicines and Healthcare products Regulatory Agency, 11 April 2014

Checklists providing a practical guide to using medical devices.

Type:

Prescribing and Technical Information (Remove filter)

Source:

Scottish Medicines Consortium - SMC (Remove filter)

15 January 2018

Indication: Treatment of the following infections in adults: • complicated intra-abdominal Infection (cIAI) • complicated urinary tract infection (cUTI), including pyelonephritis • hospital-acquired...

Type:

Prescribing and Technical Information (Remove filter)

Type:

Guidance (Add filter)

Source:

Scottish Medicines Consortium - SMC (Remove filter)

09 April 2018

Indication: Treatment of acute otitis externa in adults and children older than 1 year with an intact tympanic membrane, caused by ciprofloxacin susceptible microorganisms.

Type:

Prescribing and Technical Information (Remove filter)

Type:

Guidance (Add filter)

Source:

Scottish Medicines Consortium - SMC (Remove filter)

12 February 2018

Indication: Treatment of adult patients with highly active relapsing multiple sclerosis (MS) as defined by clinical or imaging features.

Type:

Prescribing and Technical Information (Remove filter)

Type:

Guidance (Add filter)

Source:

Scottish Medicines Consortium - SMC (Remove filter)

11 June 2018

Indication: Treatment of adults with ROS1-positive advanced non-small cell lung cancer.

Type:

Prescribing and Technical Information (Remove filter)

Type:

Guidance (Add filter)

Source:

Scottish Medicines Consortium - SMC (Remove filter)

09 October 2017

Indication: Maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (COPD) who are not adequately treated by a combination of an inhaled corticosteroid...

Type:

Prescribing and Technical Information (Remove filter)

Type:

Guidance (Add filter)

Source:

Scottish Medicines Consortium - SMC (Remove filter)

15 January 2018

Indication: For the prevention of uterine atony following delivery of the infant by Caesarean section under epidural or spinal anaesthesia.

Type:

Prescribing and Technical Information (Remove filter)

Type:

Guidance (Add filter)

Source:

Scottish Medicines Consortium - SMC (Remove filter)

15 January 2018

Indication: treatment of complicated skin and soft tissue infections in children from the age of 2 months • community-acquired pneumonia in children from the age of 2 months

Type:

Prescribing and Technical Information (Remove filter)

Type:

Guidance (Add filter)